Potential osteogenic differentiation of cisplatin-resistant rat malignant fibrous histiocytoma-derived cell lines

Experimental and Toxicologic Pathology

Volumn 58, Issue 5, 2007, Pages 299-309

  Yamate, Jyoji ^a   Kotera, Takashi ^a   Kuwamura, Mitsuru ^a   Kotani, Takao ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Bone morphogenetic proteins; Cancer differentiation based therapy; Histogenesis; Malignant fibrous histiocytoma; Osteogenic differentiation; Osteopontin; Rat cisplatin resistant cell lines

Indexed keywords

A3 ANTIBODY; ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; CELL ANTIBODY; CISPLATIN; ED1 ANTIBODY; ED2 ANTIBODY; MESSENGER RNA; OSTEOPONTIN; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CANCER CELL CULTURE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL SHAPE; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; FIBROBLAST; HISTIOCYTE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT FIBROUS HISTIOCYTOMA; MYOFIBROBLAST; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

RATTUS;

EID: 33947704754     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2006.11.008     Document Type: Article

References (34)

1. Bodamyali T., Bhatt B., Hughes F.J., Winrow V.R., Kanczler J.M., Simon B., et al. Pulsed electromagnetic fields simultaneously induce osteogenesis and upregulate transcription of bone morphogenetic protein 2 and 4 in rat osteoblasts in vitro. Biochem Biophys Res Commun 250 (1998) 458-461
2. Champagne C.M., Takebe J., Offenbacher S., and Cooper L.F. Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone 30 (2002) 26-31
3. Damoiseaux J.G., Döpp E.A., Calame W., Chao D., MacPherson G.G., and Dijkstra C.D. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83 (1994) 140-147
4. Diwan B.A., Anderson L.M., Rehm S., and Ricce J.M. Transplacental carcinogenicity of cisplatin; initiation of skin tumors and induction of other preneoplastic and neoplastic lesions in SENCAR mice. Cancer Res 53 (1993) 3874-3876
5. Fletcher C.D. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 48 (2006) 3-12
6. Genberg M., Mark J., Hakelius L., Ericsson J., and Nister M. Origin and relationship between different cell types in malignant fibrous histiocytoma. Am J Pathol 135 (1989) 1185-1196
7. Gilbert L., He X., Farmer P., Boden S., Kozlowski M., Rubin J., et al. Inhibition of osteoblast differentiation by tumor necrosis factor-α. Endocrinology 141 (2000) 3956-3964
8. Gruber R., Kandler B., Fischer M.B., and Watzek G. Osteogenic differentiation induced by bone morphgenetic proteins can be suppressed by platelet-released supernatant in vitro. Clin Oral Implants Res 17 (2006) 188-193
9. Hashimoto H., Daimaru Y., Tsuneyoshi M., and Enjoji M. Soft tissue sarcoma with additional anaplastic components: a clinicopathologic and immunohistochmeical study of 27 cases. Cancer 66 (1990) 1578-1589
10. Iwasaki H., Isoyama T., Ohjimi Y., Kikuchi M., Yoh S., Shinohara N., et al. Malignant fibrous histicytoma: a tumor of facultative histiocytes showing mesenchymal differentiation in cultured cell lines. Cancer 69 (1992) 437-447
11. Karageorgiou V., Meinel L., Hofmann S., Malhotra A., Volloch V., and Kaplan D. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A 71 (2004) 528-537
12. Kawashima R., Mochida S., Matsui A., YouLuTuz Y., Ishikawa K., Toshima K., et al. Expression of osteopontin in Kupffer cells and hepatic macrophages and stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun 256 (1999) 527-531
13. Kikuchi Y., Miyauchi M., Kizawa I., Oomori K., and Kato K. Establishment of a cisplatin-resistant human ovarian cell line. J Natl Cancer Inst 77 (1986) 1181-1185
14. Konishi Y., Maruyama H., Mii Y., Miyauchi Y., Yokose Y., and Masuhara K. Malignant fibrous histiocytoma induced by 4-(hydroxyamino)quinoline 1-oxide in rats. J Natl Cancer Inst 68 (1982) 859-865
15. Kumagai D., Yamate J., Tajima T., Tsukamoto Y., Yasui H., Kuwamura M., et al. Distribution of cells labelled by a monoclonal antibody (A3) against a cloned cell line derived from a rat malignant fibrous histiocytoma. J Comp Pathol 123 (2000) 77-87
16. Leuschner I., Heuer T., and Harms D. Induction of drug resistant in human rhabdomyosarcoma cell lines is associated with increased maturation: possible explanation for differentiation in recurrences?. Pediatr Dev Pathol 5 (2002) 276-282
17. Makiishi-Shimobayashi C., Tsujimura T., Iwasaki T., Kakihana N., Shimano K., Terada N., et al. Localization of osteopontin at calcification sites of cholesteatoma: possible role as a regulator of deposition of calcium phosphate in the middle ear. Auris Nasus Larynx 31 (2004) 3-9
18. Marchal J.A., Melguizo C., Prados J., Aránega A.E., Gómez A., Campos J., et al. Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602). Jpn J Cancer Res 91 (2000) 934-940
19. Melguizo C., Prados J., Aneiros J., Femandez J.E., Velez C., and Aranega A. Differentiation of a human rhabdomyosarcoma cell line after antineoplastic drug treatment. J Pathol 175 (1995) 23-29
20. Mizutani Y., Sato N., Kawauchi A., Nonomura N., Fukushima M., and Miki T. Cisplatin-induced in vivo differentiation of human embryonal carcinoma. BJU Int 89 (2002) 454-458
21. Nikitin A.Yu., Rajewsky M.F., and Pozharisski K.M. Development of malignant fibrous histiocytoma induced by 7,12-dimethylbenz[a]anthracene in the rat: characterization of early atypical cells. Virchows Arch 64 (1993) 151-159
22. Okubo Y., Bessho K., Fujimura K., Kusumoto K., Ogawa Y., and Iizuka T. Expression of bone morphogenetic protein in the course of osteoinduction by recombinant human bone morphogenetic protein-2. Clin Oral Implants Res 13 (2002) 80-85
23. Shibata M., Izumi K., Sano N., Akagi A., and Otsuka H. Induction of soft tissue tumors in F344 rats by subcutaneous, intramuscular, and retroperitoneal injection of nickel sulphide (Ni3S2). J Pathol 157 (1989) 263-274
24. Shimada S., Ishizawa T., Ishizawa K., Kamada K., and Hirose T. Dedifferentiated liposarcoma with rhabodomyoblastic differentiation. Virchows Arch 447 (2005) 835-841
25. Suga K., Saitoh M., Fukushima S., Takahashi K., Nara H., Yasuda S., et al. Interleukin-11 induces osteoblast differentiation and acts synergistically with bone morphogenetic protein-2 in C3H10T1/2 cells. J Interferon Cytokine Res 21 (2001) 695-707
26. Taguchi S., Kuriwaki K., Souda M., Funato M., Ninomiya K., Umekita Y., et al. Induction of sarcomas by a single subcutaneous injection of 7,12-dimethylbenza[a]anthracene into neonatal male Sprague-Dawley rats: histopathological and immunohistochemical analyses. Toxicol Pathol 34 (2006) 336-347
27. Takeya M., Yamashiro S., Yoshimura T., and Takahashi K. Immunophenotypic and immunoelectron microscopic characterization of major constituent cells in malignant fibrous histiocytoma using human cell lines and their transplanted tumors in immunodeficient mice. Lab Invest 72 (1995) 679-688
28. Tsujino K., Yamate J., Tsukamoto Y., Kumagai D., Kannan Y., Jippo T., et al. Establishment and characterization of cell lines derived from a transplantable rat malignant meningioma: morphological heterogeneity and production of nerve growth factor. Acta Neuropathol (Berl) 93 (1997) 461-470
29. Tos A.P. Classification of pleomorphic sarcomas: where are we now?. Histopathology 48 (2006) 51-62
30. Weiss S.W., and Goldblum M.D. Malignant fibrohistiocytic tumors. In: Enzinger F.M., and Weiss S.W. (Eds). Soft tissue tumors. fourth ed (2002), Mosby company, St. Louis 539-569
31. Yamashiro S., Takeya M., Nishi T., Kuratsu J., Yoshimura T., Ushio Y., et al. Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am J Pathol 145 (1994) 856-867
32. Yamate J., Tajima M., Shibuya K., Ihara M., and Kudow S. Morphologic characteristics of a transplantable tumor derived from a spontaneous malignant fibrous histiocytoma in the rat. Jpn J Vet Sci 51 (1989) 587-596
33. Yamate J., Tajima M., Togo M., Shibuya N., Shibuya K., and Kudow S. Characteristics of in vitro passaged cells derived from a rat transplantable malignant fibrous histiocytoma. Jpn J Vet Sci 51 (1989) 861-869
34. Yamate J., Kuriyama T., Kawashima M., Nakanishi M., Ide M., Kuwamura M., et al. Establishment and characterization of transplantable tumor line (KB) and cell lines (KB-P and KB-D8) from a rat thymus-derived dendritic cell sarcoma. Virchows Arch 440 (2002) 616-626